Open AccessA Phase 1b clinical trial of LDE225 (Sonidegib) in combination with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFIRINOX) in previously untreated locally advanced or metastatic pancreatic adenocarcinoma
Author(s) -
Jeffrey W. Clark,
Nora Horick,
Jill N. Allen,
Lawrence S. Blaszkowsky,
Janet E. Murphy,
Charles S. Fuchs,
Brian M. Wolpin,
Robert J. Mayer,
Jason E. Farris,
Jennifer A. Chan,
Kimmie Ng,
Nadine J. McCleary,
Thomas A. Abrams,
David P. Ryan,
Eunice L. Kwak,
Theodore S. Hong
Publication year - 2021
Publication title -
annals of pancreatic cancer
Language(s) - English
Resource type - Journals
ISSN - 2616-2741
DOI - 10.21037/apc-20-41
Subject(s) - folfirinox , oxaliplatin , irinotecan , medicine , fluorouracil , oncology , gemcitabine , adenocarcinoma , metastatic adenocarcinoma , chemotherapy , colorectal cancer , cancer